Approval · Notice of Compliance 12740 · 2011
INCIVEK: Notice of Compliance 12740
Issued August 16, 2011
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 12740
- Date
- August 16, 2011
- Company
- Vertex Pharmaceuticals (Canada) IncorporatedToronto, Ontario, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- New Drug Submission (NDS)
- Submission class
- Priority-NAS
- Therapeutic class
- Antiviral Agent
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| INCIVEK | 02371553 | Cancelled Post Market |
Medicinal ingredients
- TELAPREVIR 375 MG per TAB